Join
Live feed
·
INSIDERFilingvia Quantisnow
Galera Therapeutics Inc. logo

President and CEO Sorensen Mel sold $1,407 worth of shares (70,000 units at $0.02), decreasing direct ownership by 26% to 195,029 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GRTX· Galera Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GRTX (Galera Therapeutics Inc.) and more on Quantisnow.